Stability of retinoblastoma gene expression determines the tumorigenicity of reconstituted retinoblastoma cells
- PMID: 1504016
Stability of retinoblastoma gene expression determines the tumorigenicity of reconstituted retinoblastoma cells
Abstract
Mutational inactivation of the retinoblastoma gene (RB) is an invariant feature of the childhood eye cancer retinoblastoma and of tumor cells derived therefrom. In a previous study, retrovirus-mediated transfer of wild-type RB into cultured retinoblastoma cells resulted in a marked enlargement and reduced growth rate of these cells, as well as loss of their tumorigenic properties in nude mice. It was therefore difficult to separate the proposed growth-suppressing and tumor-suppressing activities of RB protein. Here, we show that clones of RB-reconstituted retinoblastoma cells can be isolated that stably express apparently normal RB protein for at least 20 months of continuous culture. These clones were indistinguishable from nonreconstituted cells by multiple parameters including morphology, growth rate, and cell cycle distribution. Despite similar phenotypes in culture, clones with stable RB expression were uniformly nontumorigenic in nude mice, whereas those that lost such expression regained their tumorigenic properties. These results indicate that the tumorigenicity of these cells is entirely determined by the presence or absence of exogenous RB protein expression and that suppression of tumorigenicity is distinct from inhibition of cellular growth in culture.
Similar articles
-
Changes in growth and tumorigenicity following reconstitution of retinoblastoma gene function in various human cancer cell types by microcell transfer of chromosome 13.Cancer Res. 1992 Nov 15;52(22):6297-304. Cancer Res. 1992. PMID: 1423276
-
The molecular basis of cancer suppression by the retinoblastoma gene.Princess Takamatsu Symp. 1989;20:159-70. Princess Takamatsu Symp. 1989. PMID: 2488231
-
Intraocular tumor suppression of retinoblastoma gene-reconstituted retinoblastoma cells.Cancer Res. 1991 Dec 1;51(23 Pt 1):6381-4. Cancer Res. 1991. PMID: 1933901
-
The molecular genetics of retinoblastoma.Cancer Surv. 1990;9(3):529-54. Cancer Surv. 1990. PMID: 2101724 Review.
-
[The retinoblastoma gene: from its basic understanding as a signal mediator for growth and differentiation to its use in the treatment of cancer].Gan To Kagaku Ryoho. 1997 Sep;24(11):1368-80. Gan To Kagaku Ryoho. 1997. PMID: 9309128 Review. Japanese.
Cited by
-
The transcription factor E2F-1 mediates the autoregulation of RB gene expression.Mol Cell Biol. 1994 Jan;14(1):299-309. doi: 10.1128/mcb.14.1.299-309.1994. Mol Cell Biol. 1994. PMID: 8264596 Free PMC article.
-
The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator.Mol Cell Biol. 1994 Jul;14(7):4380-9. doi: 10.1128/mcb.14.7.4380-4389.1994. Mol Cell Biol. 1994. PMID: 8007947 Free PMC article.
-
Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F.Mol Cell Biol. 1992 Dec;12(12):5620-31. doi: 10.1128/mcb.12.12.5620-5631.1992. Mol Cell Biol. 1992. PMID: 1448092 Free PMC article.
-
The amino-terminal region of the retinoblastoma gene product binds a novel nuclear matrix protein that co-localizes to centers for RNA processing.J Cell Biol. 1994 Nov;127(3):609-22. doi: 10.1083/jcb.127.3.609. J Cell Biol. 1994. PMID: 7525595 Free PMC article.
-
The cell cycle and the retinoblastoma protein family.Cancer Metastasis Rev. 1994 Mar;13(1):45-66. doi: 10.1007/BF00690418. Cancer Metastasis Rev. 1994. PMID: 8143345 Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical